ORGANOGENESIS HOLDINGS INC. Income Tax Expense
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Income Tax Expense of $45.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $45.39M.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for the quarter ending 2026-03-31 was -$15.32M.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $19.73M, a 664.61% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$407.00K.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for fiscal 2025 was $9.94M.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for fiscal 2024 was -$3.67M, a 167.34% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for fiscal 2023 was $5.45M, a 14.67% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. income tax expense (benefit) for fiscal 2022 was $4.75M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.39M 10-Q · filed 2026-08-06 | $30.07M 10-Q · filed 2026-08-06 | $49.80M derived: sum of 3 quarters · filed 2026-08-06 | $49.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$15.32M 10-Q · filed 2026-05-07 | $4.41M derived: sum of 2 quarters · filed 2026-05-07 | $4.00M derived: sum of 3 quarters · filed 2026-05-07 | $1.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.32M derived: sum of 2 quarters · filed 2026-02-26 | $16.88M derived: sum of 3 quarters · filed 2026-08-06 | $9.94M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$407.00K 10-Q · filed 2025-11-06 | -$2.85M derived: sum of 2 quarters · filed 2026-08-06 | -$9.79M 10-Q · filed 2025-11-06 | -$7.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.44M 10-Q · filed 2026-08-06 | -$9.38M 10-Q · filed 2026-08-06 | -$6.80M derived: sum of 3 quarters · filed 2026-08-06 | -$13.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$6.94M 10-Q · filed 2026-05-07 | -$4.36M derived: sum of 2 quarters · filed 2026-05-07 | -$10.87M derived: sum of 3 quarters · filed 2026-05-07 | -$8.37M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.93M derived: sum of 2 quarters · filed 2026-02-26 | -$1.43M derived: sum of 3 quarters · filed 2026-02-26 | -$3.67M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$6.51M 10-Q · filed 2025-11-06 | -$4.00M derived: sum of 2 quarters · filed 2025-11-06 | -$6.25M 10-Q · filed 2025-11-06 | -$7.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.50M 10-Q · filed 2025-08-07 | $260.00K 10-Q · filed 2025-08-07 | -$968.00K derived: sum of 3 quarters · filed 2026-02-26 | $3.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$2.24M 10-Q · filed 2025-05-08 | -$3.47M derived: sum of 2 quarters · filed 2026-02-26 | $999.00K derived: sum of 3 quarters · filed 2026-02-26 | $4.86M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.24M derived: sum of 2 quarters · filed 2026-02-26 | $7.11M derived: sum of 3 quarters · filed 2026-02-26 | $5.45M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.47M 10-Q · filed 2024-11-12 | $8.33M derived: sum of 2 quarters · filed 2024-11-12 | $6.67M 10-Q · filed 2024-11-12 | $7.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.86M 10-Q · filed 2024-08-08 | $2.21M 10-Q · filed 2024-08-08 | $3.47M derived: sum of 3 quarters · filed 2025-02-27 | $4.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.66M 10-Q · filed 2024-05-09 | -$390.00K derived: sum of 2 quarters · filed 2025-02-27 | $607.00K derived: sum of 3 quarters · filed 2025-02-27 | $3.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.27M derived: sum of 2 quarters · filed 2025-02-27 | $4.71M derived: sum of 3 quarters · filed 2025-02-27 | $4.75M 10-K · filed 2025-02-27 |
| 2022-09-30 | $997.00K 10-Q · filed 2023-11-09 | $3.44M derived: sum of 2 quarters · filed 2023-11-09 | $3.48M 10-Q · filed 2023-11-09 | -$28.62M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.44M 10-Q · filed 2023-08-09 | $2.48M 10-Q · filed 2023-08-09 | -$29.62M derived: sum of 3 quarters · filed 2024-02-29 | -$29.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $45.00K 10-Q · filed 2023-05-10 | -$32.06M derived: sum of 2 quarters · filed 2024-02-29 | -$31.76M derived: sum of 3 quarters · filed 2024-02-29 | -$31.27M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$32.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$31.80M derived: sum of 2 quarters · filed 2024-02-29 | -$31.32M derived: sum of 3 quarters · filed 2024-02-29 | -$31.12M 10-K · filed 2024-02-29 |
| 2021-09-30 | $303.00K 10-Q · filed 2022-11-09 | $790.00K derived: sum of 2 quarters · filed 2022-11-09 | $990.00K 10-Q · filed 2022-11-09 | $1.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $487.00K 10-Q · filed 2022-08-09 | $687.00K 10-Q · filed 2022-08-09 | $1.08M derived: sum of 3 quarters · filed 2023-03-01 | $1.16M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-10 | $596.00K derived: sum of 2 quarters · filed 2023-03-01 | $668.00K derived: sum of 3 quarters · filed 2023-03-01 | $695.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $468.00K derived: sum of 2 quarters · filed 2023-03-01 | $495.00K derived: sum of 3 quarters · filed 2023-03-01 | $530.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-09 | $99.00K derived: sum of 2 quarters · filed 2021-11-09 | $134.00K 10-Q · filed 2021-11-09 | $176.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $27.00K 10-Q · filed 2021-08-09 | $62.00K 10-Q · filed 2021-08-09 | $104.00K derived: sum of 3 quarters · filed 2022-03-01 | $152.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $35.00K 10-Q · filed 2021-05-11 | $77.00K derived: sum of 2 quarters · filed 2022-03-01 | $125.00K derived: sum of 3 quarters · filed 2022-03-01 | $148.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $90.00K derived: sum of 2 quarters · filed 2022-03-01 | $113.00K derived: sum of 3 quarters · filed 2022-03-01 | $150.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $48.00K 10-Q · filed 2020-11-09 | $71.00K derived: sum of 2 quarters · filed 2020-11-09 | $108.00K 10-Q · filed 2020-11-09 | $110.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $23.00K 10-Q · filed 2020-08-10 | $60.00K 10-Q · filed 2020-08-10 | $62.00K derived: sum of 3 quarters · filed 2020-08-10 | $89.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $37.00K 10-Q · filed 2020-05-11 | $39.00K derived: sum of 2 quarters · filed 2020-05-11 | $66.00K derived: sum of 3 quarters · filed 2020-05-11 | $93.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.00K 10-K · filed 2019-03-18 | $29.00K derived: sum of 2 quarters · filed 2019-11-12 | $56.00K derived: sum of 3 quarters · filed 2019-11-12 | $84.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $27.00K 10-Q · filed 2019-11-12 | $54.00K derived: sum of 2 quarters · filed 2019-11-12 | $82.00K 10-Q · filed 2019-11-12 | -$151.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $27.00K 10-Q · filed 2019-08-09 | $55.00K 10-Q · filed 2019-08-09 | -$178.00K derived: sum of 3 quarters · filed 2019-08-09 | -$131.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $28.00K 10-Q · filed 2019-05-10 | -$205.00K derived: sum of 2 quarters · filed 2019-05-10 | -$158.00K derived: sum of 3 quarters · filed 2019-05-10 | -$314.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$233.00K 10-K · filed 2019-03-18 | -$186.00K derived: sum of 2 quarters · filed 2019-03-18 | -$342.00K derived: sum of 3 quarters · filed 2019-03-18 | -$7.03M 10-K · filed 2020-03-09 |
| 2017-09-30 | $47.00K 10-K · filed 2019-03-18 | -$109.00K derived: sum of 2 quarters · filed 2019-03-18 | -$6.79M derived: sum of 3 quarters · filed 2019-03-18 | |
| 2017-06-30 | -$156.00K 10-K · filed 2019-03-18 | -$6.84M derived: sum of 2 quarters · filed 2019-03-18 | ||
| 2017-03-31 | -$6.68M 10-K · filed 2019-03-18 | |||
| 2016-12-31 | $65.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |